The Deutsches Herzzentrum Berlin is a medical research centre in Berlin, Germany, specialised in cardiovascular disease, as well as cardiopulmonary transplantation. The hospital has two CMR scanners. A new heart centre is planned to be built in 2018 and finish construction in 2021.

During the past decade, Herzzentrum Berlin, Ped Cardiology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Berlin, Ped Cardiology" are "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Herzzentrum Berlin, Ped Cardiology" in a lesser frequency.

Most popular intervention types in "Herzzentrum Berlin, Ped Cardiology" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Macitentan 10 mg" (1 trials), "Macitentan 10 mg tablet, once daily." (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Berlin, Ped Cardiology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Herzzentrum Berlin, Ped Cardiology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Herzzentrum Berlin, Ped Cardiology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Berlin, Ped Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".